IN2014DN09713A - - Google Patents

Info

Publication number
IN2014DN09713A
IN2014DN09713A IN9713DEN2014A IN2014DN09713A IN 2014DN09713 A IN2014DN09713 A IN 2014DN09713A IN 9713DEN2014 A IN9713DEN2014 A IN 9713DEN2014A IN 2014DN09713 A IN2014DN09713 A IN 2014DN09713A
Authority
IN
India
Prior art keywords
eye
patient
lacrimal
intraocular pressure
punctum
Prior art date
Application number
Other languages
English (en)
Inventor
Deepank Utkhede
Suzanne Cadden
Yong Hao
Original Assignee
Quadra Logic Tech Inc
Deepank Utkhede
Suzanne Cadden
Yong Hao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc, Deepank Utkhede, Suzanne Cadden, Yong Hao filed Critical Quadra Logic Tech Inc
Publication of IN2014DN09713A publication Critical patent/IN2014DN09713A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Prostheses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
IN9713DEN2014 2012-05-03 2014-11-18 IN2014DN09713A (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261642287P 2012-05-03 2012-05-03
US201261644397P 2012-05-08 2012-05-08
US201261644401P 2012-05-08 2012-05-08
US201261659921P 2012-06-14 2012-06-14
US201261680641P 2012-08-07 2012-08-07
US201261717615P 2012-10-23 2012-10-23
PCT/IB2013/000694 WO2013164671A1 (fr) 2012-05-03 2013-02-27 Système d'administration de médicament et procédés de traitement d'un glaucome à angle ouvert et de l'hypertension oculaire

Publications (1)

Publication Number Publication Date
IN2014DN09713A true IN2014DN09713A (fr) 2015-07-31

Family

ID=49514247

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9713DEN2014 IN2014DN09713A (fr) 2012-05-03 2014-11-18

Country Status (7)

Country Link
EP (1) EP2844224B1 (fr)
JP (1) JP6213560B2 (fr)
CN (1) CN105473130A (fr)
CA (1) CA2872338C (fr)
HK (1) HK1222810A1 (fr)
IN (1) IN2014DN09713A (fr)
WO (1) WO2013164671A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012021107A2 (fr) 2010-08-12 2012-02-16 Nanyang Technological University Formulation de liposomes pour l'administration d'un médicament dans l'œil
US9956195B2 (en) 2014-01-07 2018-05-01 Nanyang Technological University Stable liposomal formulations for ocular drug delivery
GB201714392D0 (en) * 2017-09-07 2017-10-25 Marsteller Laurence Methods and devices for treating glaucoma

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321108A (en) 1965-11-26 1967-05-23 William E Bowe Printing ink dispenser
US3681608A (en) 1971-03-17 1972-08-01 Us Navy Laser beam receiver having a high signal to noise ratio
US4281654A (en) 1980-04-07 1981-08-04 Alza Corporation Drug delivery system for controlled ocular therapy
US4952581A (en) 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
US4936008A (en) 1988-05-09 1990-06-26 Teledyne Mec Laser striping method for assembling TWT
US4934708A (en) 1988-05-20 1990-06-19 Kolkind Gerald L Family quiz board game
US5296504A (en) 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5259508A (en) 1992-08-27 1993-11-09 Beckerman Stephen M Protective shipping package
DE69311361T2 (de) 1992-10-13 1998-01-08 Alcon Lab Inc Zusammensetzungen zur behandlung von glaukoma die prostaglandine und clonidinderivate enthalten
US6622308B1 (en) 1999-03-23 2003-09-16 Scientific-Atlanta, Inc. Automatic digital television (DTV) bypass for a CATV converter using a CATV tuner
US6534693B2 (en) 2000-11-06 2003-03-18 Afmedica, Inc. Surgically implanted devices having reduced scar tissue formation
US7300364B2 (en) 2004-02-06 2007-11-27 Acushnet Company Multi-layer golf ball having velocity gradient from faster center to slower cover
JP2006520217A (ja) 2003-02-26 2006-09-07 メディバス エルエルシー 生物活性ステントおよびその使用方法
JP4104137B2 (ja) * 2003-05-30 2008-06-18 有限会社エム・エル・シー 涙点プラグ
US7662864B2 (en) 2003-06-04 2010-02-16 Rutgers, The State University Of New Jersey Solution polymerization processes to prepare a polymer that degrades to release a physiologically active agent
US20050129731A1 (en) 2003-11-03 2005-06-16 Roland Horres Biocompatible, biostable coating of medical surfaces
NZ548271A (en) 2004-01-05 2010-01-29 Nicox Sa Prostaglandin nitrooxyderivatives
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
CA2572592C (fr) 2004-07-02 2015-09-08 Eliot Lazar Dispositif de mise en place d'un moyen de traitement et methodes destinees a la mise en place dans l'oeil de ce type de moyen de traitement a l'aide dudit dispositif de mise en place
JP5208916B2 (ja) 2006-03-31 2013-06-12 キュー エル ティー インク． 鼻涙系用の薬物送達方法、構造および組成物
JP2010514517A (ja) * 2006-12-26 2010-05-06 キューエルティー プラグ デリバリー，インク． 視覚欠損の抑制のための薬物送達インプラント
UY30883A1 (es) 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos
CA2698580C (fr) 2007-09-07 2016-10-11 Qlt Plug Delivery, Inc. Detection d'un implant lacrymal
MX2010002616A (es) 2007-09-07 2010-08-04 Qlt Plug Delivery Inc Nucleos de farmaco para la liberacion sostenida de agentes terapeuticos.
KR20100058620A (ko) 2007-09-07 2010-06-03 큐엘티 플러그 딜리버리, 인코포레이티드 눈물 임플랜트용 삽입 및 적출 기구
EP2865361B1 (fr) 2007-09-07 2019-05-22 Mati Therapeutics Inc. Implants lacrymaux et procédés associés
CA2722971C (fr) * 2008-05-09 2019-05-07 Qlt Plug Delivery, Inc. Administration d'agents actifs a liberation prolongee pour traiter le glaucome et l'hypertension oculaire
US20100209477A1 (en) 2009-01-23 2010-08-19 Qlt Plug Delivery Inc. Sustained release delivery of one or more agents
SG174133A1 (en) * 2009-02-23 2011-10-28 Quadra Logic Tech Inc Lacrimal implants and related methods
WO2011066479A1 (fr) 2009-11-27 2011-06-03 Qlt Plug Delivery, Inc. Implants lacrimaux contenant un noyau de médicament fendu et insérable

Also Published As

Publication number Publication date
EP2844224A1 (fr) 2015-03-11
CA2872338C (fr) 2021-09-14
JP2015520628A (ja) 2015-07-23
CN105473130A (zh) 2016-04-06
CA2872338A1 (fr) 2013-11-07
EP2844224B1 (fr) 2018-04-11
HK1222810A1 (zh) 2017-07-14
EP2844224A4 (fr) 2016-02-24
JP6213560B2 (ja) 2017-10-18
WO2013164671A1 (fr) 2013-11-07

Similar Documents

Publication Publication Date Title
WO2013030679A3 (fr) Administration à libération prolongée d'agents actifs pour traiter le glaucome et l'hypertension oculaire
MX2018014763A (es) Suministro intraocular de farmacos.
WO2010105130A3 (fr) Système d'administration de médicament ophtalmique et applications
MX2020002381A (es) Implantes intraoculares que contienen prostamida y metodos para su uso.
CA3010374A1 (fr) Reduction de la pression intra-oculaire avec des implants de bimatoprost intracamerulaires
WO2010085696A3 (fr) Système d'administration à libération prolongée d'un ou plusieurs agents
WO2009105690A3 (fr) Dispositifs et méthodes pour l'introduction de polynucléotides dans des cellules rétiniennes de la macula et de la fovéa
WO2010093945A3 (fr) Implant médicamenteux uvéoscléral et ses procédés d'implantation
TW200603775A (en) Anti-excitotoxic sustained release intraocular implants and related methods
WO2012071476A3 (fr) Implant oculaire à élution de médicament
MX2010012022A (es) Suministro de liberacion sostenida de agentes activos para tratar glaucoma e hipertension ocular.
EA201590502A1 (ru) Система доставки глазного имплантата
MX2019002861A (es) Composicion farmaceutica.
IL212113A (en) A device for the implantation of a drug for glaucoma treatment
WO2014143754A3 (fr) Implant intraoculaire contenant de la prostamide
WO2012167167A3 (fr) Shunt oculaire ayant une structure poreuse
WO2012033730A3 (fr) Bouchon méatique contenant une préparation médicamenteuse
WO2011159761A3 (fr) Bouchons méatiques avec mécanisme de libération de médicament continue ou pulsée
TWD159201S (zh) 眼內鏡片植入具用鏡片保持引導具之部分
MX2016001300A (es) Estructura de lente intraocular.
IN2014DN09713A (fr)
Richoz et al. Crosslinking for recurrent keratoconus
MX2022002306A (es) Metodos de tratamiento de enfermedades oculares con un implante para la administracion sostenida de farmacos.
RU2010135224A (ru) Способ хирургического лечения макулярного отека после факоэмульсификации катаракты
MX2020011535A (es) Formulacion de gotas para ojos y metodos para la liberacion sostenida de medicamento a la retina.